Beltsville, MD, USA – REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system licensed from Profluent (Emeryville, CA, USA). StemEdit encompasses REPROCELL’s proprietary clinical gene-editing technology and its new gene-edited iPSC lines that are ready for immediate use. These offerings combine REPROCELL’s StemRNA™ [...]

Dr. Hailing Shi to apply 3D spatial multi-omics to decode RNA regulation in the human brain and neurodegenerative diseases BOSTON -- Stellaromics, a pioneer in high-resolution 3D spatial biology, today announced the installation of its Pyxa™ 3D spatial multi-omics system at Emory University School of Medicine. Emory becomes the third beta program site following successful deployments [...]

Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA sequencing and array-based technologies, to provide Illumina sequencing instruments and related products to Devyser customers. Under the agreement, Devyser will be able to offer selected Illumina sequencing instruments together with Devyser’s reagent solutions, enabling customers to access advanced sequencing [...]

First U.S. commercial agreement delivers next-generation technology for faster, more accurate diagnostics BURLINGTON, N.C. – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that it is the first U.S. commercial laboratory with an agreement to implement Roche’s cobas® Mass Spec solution. This collaboration introduces fully automated mass spectrometry into [...]

Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology  Nautilus’ development of a single-molecule assay for measuring alpha-synuclein proteoforms is its latest application of Iterative Mapping method to uncover new biological insights Weill Cornell Medicine-Qatar’s deep chemical biology and neurology expertise and field-leading protein standards and [...]

Detects low-abundance proteins in blood at femtogram concentrations for earlier disease insights Supports research in Alzheimer's, ALS, MS, Parkinson's Disease, and Traumatic Brain Injury with validated biomarkers Automated immunoassay workflow reduces variability; total runtime is under three hours MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced [...]

New platform integrates epigenetic and transcriptomic analysis in a unified workflow, addressing key challenges in single-cell multi-omics research. LONDON, UK – SeekGene, a biotechnology company specializing in single-cell technology platforms, announced the launch of its novel high-throughput single-cell DNA methylation and RNA multi-omics solution at the Festival of Genomics & BioData 2026. The solution aims to [...]

Adds Private Equity and Operational Experience to Help Scale iOrganBio’s Operations CHAPEL HILL, N.C. -- iOrganBio, an innovator in intelligent cell manufacturing redefining how human cells are engineered and reliably produced at scale for research and therapy, including as New Approach Methodologies (NAMs) in alignment with FDA direction, today announced the appointment of Karol Jarzabek [...]

Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass. -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that, at the Company's Special Meeting of Shareholders (the "Special Meeting") held today, Waters [...]

Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses Responds to growing demand for scalable, patient-relevant human models to support translational decision-making in drug development San Diego, CA: iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, and Rosebud [...]